EMAIL THIS PAGE TO A FRIEND

PloS one

Sphingolipids are required for efficient triacylglycerol loss in conjugated linoleic Acid treated adipocytes.


PMID 25906159

Abstract

Conjugated linoleic acid (CLA) reduces adiposity in human and mouse adipocytes. This outcome is achieved through a variety of biological responses including increased energy expenditure and fatty acid oxidation, increased inflammation, repression of fatty acid biosynthesis, attenuated glucose transport, and apoptosis. In the current study, profiling of 261 metabolites was conducted to gain new insights into the biological pathways responding to CLA in 3T3-L1 adipocytes. Sphinganine and sphingosine levels were observed to be highly elevated in CLA treated adipocytes. Exogenous chemicals that increased endogenous ceramide levels decreased lipid levels in adipocytes, and activated AMP-activated protein kinase (AMPK) as well as NF-κB, both of which are typically activated in CLA treated adipocytes. Concurrent inhibition of ceramide de novo biosynthesis and recycling from existing sphingolipid pools attenuated the lipid lowering effect normally associated with responses to CLA, implicating ceramides as an important component of the lipid lowering response in CLA treated adipocytes.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

I5879
3-Isobutyl-1-methylxanthine, ≥99% (HPLC), powder
C10H14N4O2
B2261
bisBenzimide H 33342 trihydrochloride, ≥98% (HPLC and TLC)
C27H28N6O · 3HCl · xH2O
12138C Bovine Calf Serum, Iron-Fortified, USA origin, from formula-fed bovine calves, sterile-filtered, cell culture tested
A2153
Bovine Serum Albumin, lyophilized powder, ≥96% (agarose gel electrophoresis)
D1626
Deoxyribonucleic acid sodium salt from salmon testes
D0700000
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
1176007
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
C22H29FO5
46165
Dexamethasone, VETRANAL, analytical standard
C22H29FO5
31375
Dexamethasone, tested according to Ph.Eur.
C22H29FO5
PHR1526
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
C22H29FO5
Y0001593
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
Y0001177
Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard
C22H29FO5
S5386
DL-Serine, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥98% (HPLC)
C3H7NO3
S4375
DL-Serine, ≥98% (TLC)
C3H7NO3
P5499
Dorsomorphin, ≥98% (HPLC)
C24H25N5O
32936
Fumonisin B1, reference material
C34H59NO15
F1147
Fumonisin B1 from Fusarium moniliforme, ≥98% (HPLC)
C34H59NO15
34139
Fumonisin B1 solution, 50 μg/mL in acetonitrile: water, analytical standard
C34H59NO15
I1882 Insulin from bovine pancreas, γ-irradiated, BioXtra, suitable for cell culture, potency: ≥20 units/mg (USP units), lyophilized powder
C254H377N65O75S6
C8104 Monoclonal Anti-Ceramide antibody produced in mouse, clone MID 15B4, purified immunoglobulin, buffered aqueous solution
M1177
Myriocin from Mycelia sterilia, ≥98% (HPLC), powder
C21H39NO6
A7191
N-Acetyl-D-sphingosine, ≥97% (TLC), powder
C20H39NO3
01912
N-Acetyl-D-sphingosine, ≥98.0% (TLC)
C20H39NO3
60377
Potassium hydroxide, tested according to Ph.Eur.
HKO
757551
Potassium hydroxide, anhydrous, ≥99.97% trace metals basis
HKO
61699
Potassium hydroxide concentrate, 0.1 M KOH in water (0.1N), Eluent concentrate for IC
HKO
720143
Potassium hydroxide on alumina
HKO
00648
Potassium hydroxide solution, 28.5%, for flue-gas analysis
HKO
S0450000
Serine, European Pharmacopoeia (EP) Reference Standard
C3H7NO3
TR0100 Serum Triglyceride Determination Kit,  kit sufficient for 250 tests